New research from The Cooper Institute® + partners shows exercising, even at very high levels, is unrelated to progression of coronary artery calcium (CAC)
Tag: cardiovascular
ConcertAI’s TeraRecon Adds Cardio Suite to its Eureka Clinical AI Platform
CAMBRIDGE, Mass., Aug. 30, 2023 /PRNewswire/ — Concert AI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced today that its Eureka Clinical AI platform’s Cardio Suite now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to help identify, treat, and manage cardiovascular disease. Eureka Clinical AI […]
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years
EAST HANOVER, N.J., Aug. 28, 2023 /PRNewswire/ — Novartis today announced new long-term data from ORION-8, a Phase III open-label extension of ORION-9, ORION-10, ORION-11 and ORION-3 trials. The data demonstrated that with twice-yearly* dosing, Leqvio, in addition to statin therapy, provides consistent low-density lipoprotein cholesterol (LDL-C) reduction beyond six years in patients […]
FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform
THE WOODLANDS, Texas and REGENSBURG, Germany, July 25, 2023 /PRNewswire/ — The US Food and Drug Administration has cleared a Numares Health test, the AXINON® LDL-p Test System, as a new tool physicians can use to measure lipoproteins for patients at risk for cardiovascular disease. Currently, Numares is the only company in the US selling an FDA-cleared […]
Nationwide Preventive Healthcare Company, Life Line Screening, Announces Ray Li as Vice President of Product
AUSTIN, Texas–(BUSINESS WIRE)–Life Line Screening, the nation’s leading mobile preventive health screening company for cardiovascular disease and stroke risk, announces that Ray Li has joined the organization as Vice President of Product. Mr. Li joins Life Line Screening as the business is focused on providing the highest level of preventive […]
IDx Founder Awarded Patent for System that Automatically Detects Measure of Cardiovascular Health
IOWA CITY, Iowa, March 29, 2018 /PRNewswire/ — IDx, a privately-held AI diagnostics company, today announced its founder and president, Michael Abramoff, MD, PhD, has been awarded U.S. Patent No. 9,924,867 for a system that can automatically measure arterial and venous diameters in blood vessels, an important predictor of cardiovascular health. “It is exciting that […]
Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
NETANYA, Israel, October 26, 2017 /PRNewswire/ — Nitiloop, a medical device company dedicated to the development of Cardiovascular and peripheral microcatheters for complex lesions, received FDA clearance for its new Nova Cross™ Extreme and Nova Cross™ BTK. These dedicated microcatheters are joining the Nova Cross™ product family combining innovative low profile microcatheter technology with uniquely designed Nitinol scaffold providing […]
BTG to buy Roxwood Medical for up to $80 million
UK’s BTG to buy Roxwood Medical for up to $80 million Reuters Staff Reporting by Radhika Rukmangadhan in Bengaluru; editing by Jason Neely Our Standards:The Thomson Reuters Trust Principles. (Reuters) – British drugs company BTG Plc (BTG.L) said on Thursday it will buy U.S.-based cardiovascular catheter maker Roxwood Medical for […]
Meta-Analysis Shows RenalGuard(R) Offers Dramatic Benefit for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Cardiovascular Interventions
MILFORD, MA–(Marketwired – September 13, 2017) – A new meta-analysis suggests that the use of the RenalGuard System® reduces the rate of contrast-induced acute kidney injury (CI-AKI) compared to standard intravascular volume expansion in moderate-to-high-risk patients with chronic kidney disease who are undergoing cardiac interventional procedures. The study, published in the Journal […]
Recent
VentureMed Strengthens Commercial Leadership and Expands Clinical Evidence to Drive FLEX Vessel Prep™ System Growth
Growing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for Use
Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA Cardiology
Popular
- No commented posts yet